MDxHealth Inc. (MDXH): רווח נקי למניה (EPS TTM)
The high macro-resilience of prostate cancer diagnostics ensures stable demand, allowing MDxHealth SA to effectively leverage cloud data outsourcing. The company's 12-month profit per unit visualizes this correlation, where the -0.73 mark indicates the current state. The integration of tests into medical protocols completes the picture, guaranteeing a constant influx of new test orders.
פילוחי מדדים פיננסיים ומדדי שוק עבור MDxHealth S.A. (MDXH)
Net income per share (TTM) reflects the aggregate financial result of MDxHealth SA (MDXH) over the last twelve months, allocated per common share to evaluate actual capital efficiency. By analyzing the current trailing twelve-month net income per share, an investor determines the monetization rate of MDxHealth SA (MDXH) leadership in molecular diagnostics and the precision of the implementation of their urological testing standards.
